Immunotherapies for COVID-19: lessons learned from sepsis

Article highlights the reported biochemical response to acute respiratory distress in COVID-19 is similar to cytokine storm, and it details trials of IL-6 inhibitors underway. The paper suggests however this approach only targets symptoms rather than modulating the disease itself


The Lancet Respiratory Medicine